We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Solent Automation specialises in developing, deploying and supporting automation robots to perform and tackle common manual labour-intensive tasks in factories. To solve the 'pick-and-place' challenges in an industrial setup, these robots are created with proven reliable components coupled with proprietary software to solve 'pick-and-place' challenges in an industrial environment. Two of the company's noteworthy products are 'SOLPAL 8' and 'SOLPACK 1XP, both are equipped with an all-in-one gripping tool, and can handle 16 boxes per minute and 60 packs per minute, respectively. Backed by a team of experts from manufacturing and robotics, Solent Automation provides on-site installation, training, and remote support for its products. There is also a rent-to-buy option through a 3rd party finance company. With the investment, the company aims at providing more robotic equipment most needed in factories focused on labour-intensive work functions.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £76,000
Span Health is a digital care platform that aims to help people avoid lifestyle-induced diseases, symptoms, medication, and complications. The company has helped more than 10,000 people to live a better and longer life. Span Health's easy-to-use mobile application allows patients to chat with clinicians, order blood tests at home, book video consultations, and see results in the application itself. Moreover, in 2019, the company agreed on a National Health Service (NHS) pilot test for 100 patients in collaboration with the National Institute of Health Research in North West London. Span Health will use the investment to provide employees with blood tests to screen for health risk factors and recover from detected illness safely and sustainably, improve its platform data insights, prediction and machine learning to better structure the clinician's processes, and further reduce its operational costs.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £134,892
Fullgreen offers a range of 100% plant-based products that are low-carb and preservative-free alternatives for people looking to eat fewer carbohydrates, add more vegetables to their meals, or manage health issues such as obesity and diabetes. Fullgreen also claims that its products are shelf-stable negating the need to refrigerate. The company's catalogue includes non-Genetically Modified Organism (GMO) riced veggies, cauliflower risottos, and oat free plant-based breakfast meals, to name a few. Fullgreen points out that its products are listed in over 9,000 UK and US retailers. The company has dedicated production lines in the UK and US with a capacity of over 18 million pouches per annum. It has sold over 12 million pouches to date and earned £5.4 million in 2020. Fullgreen will use the investment to improve in-store promotions and activations, develop sampling activities for its target consumers, and boost geotargeted advertising and other digital marketing activities.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £752,246
Pharmseal is a software company that aims to disrupt clinical trial management. The company claims that companies typically use multiple applications for managing clinical trials from one or more vendors. This increases cost and complexity. Pharmaseal asserts that its cloud Business-2-Business (B2B) platform, Engility, simplifies control by providing a single management portal. The platform allows information to be centralised and accessed from a single platform. Pharmaseal claims that Engility will allow companies to save cost and time and enable them to bring life-saving drugs to market faster. The company will utilise 31% of the investment for commercialisation and marketing, 49% for product development, 13% for IT infrastructure, and 7% for administrative/legal/miscellaneous activities.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £532,311
Skin In Motion (SIM) is a first-of-its-kind exercise-friendly beauty range that seeks to promote the positive effects of exercise through healthy and confidence-boosting skincare and makeup products specifically designed to be worn pre, during, and post-exercise. SIM claims that its products are available Direct To Consumer (DTC) via its website and are listed on LookFantastic, Amazon and Oliver Bonas. SIM was awarded the 'Best New Business 2020' award by the Women's Business Club. The brand has reached 3 million potential customers and has an Instagram following of 3,000 to date. The company has also featured in Sunday Times Style Magazine, Hello!, RED Magazine, and Women's Health, to name a few. It will use the investment to grow its team, increase marketing and brand awareness, and accelerate new product developments.

Pitch Rated

78%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £166,111
EBar is a ‘Beer as a Service’ entity. It argues that music and sporting events experience long bar queues with millions of people waiting in serpentine lines for their pint. EBar aspires to change this. Its patent-protected EBar machine allows a customer to order, pay and dispense two drinks in less than 30 seconds and in half the time taken by a typical event bar. The machine is supplemented with an integrated 'Point of Sale' (PoS) software, payment solution and data reporting systems. The company has secured over £800,000 of funding from private and public sector sources to date. It also deployed new EBar units at pilot events pre-lockdown and commercially in summer 2020 where it served over 3,500 pints in a socially distanced open-air environment. EBar has patents pending across international territories such as North America, Europe, China, Japan, Korea and Australia. It will use the investment to build more units, grow its team, develop supply chain partnerships, and boost business development.

Pitch Rated

77%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £356,377
Njori is a company that has created an accurate, multi-functional cooker that can be stored on a bookshelf alongside cookbooks. The cooker uses integrated sensors and accessories to monitor and regulate the cooking process. It's built-in scales helps a user measure ingredients before and during the cooking process. The scale function also enables the user to reduce food by a set weight or percentage. The company aims to be a disruptor in the global portable induction cooker market that is set to be worth £4.5 billion by 2022. Njori has filed UK patents & is building its supply chain in China. It will use the investment to finish development and bring the final product to market.

Pitch Rated

77%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £236,797
WooHa brewing company started with a 3000 square foot and in 3 years moved to a 6.2 acre farm. WooHa is always focusing on export and US has always been their main target. They began exporting in 2016 and within a year had distribution in California, Washington DC and Tennessee. In the UK their beer can be found in supermarkets, bars and restaurants.

Pitch Rated

77%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £156,870
buyfair intends to be a premium variant of ebay for businesses. It is powered by features like multi-lot algorithm that enables huge volumes to be sold in smaller quantities and a brand safe atmosphere preserving premium brands. The company has over 500 live auctions every day, and 150 brands have already signed up across 18 countries. buyfair has also been featured in Forbes, Cosmetic Business, The Independent. buyfair is planning to use the funds for buyer acquisition, tech development and marketing.

Pitch Rated

77%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £316,160
L.A Brewery (LAB) produces non-alcoholic kombucha made from health-boosting teas, fruits, and botanicals. LAB argues that 25% of drinkers consider themselves semi-regular consumers of low and no alcohol in the UK and aims to cater to the demands of this category. LAB asserts that it has already produced and sold one million drinks and achieved listings with entities like Amazon, Selfridges, Leon, Farmdrop, Wholefoods, Planet Organic, Ocado (March 2021), and 300+ independent stockists across the UK. It has also featured in Vogue, GQ, Tatler, Hello!, Elle, and Glamour, to name a few. LAB points out that its feature on ITV's 'Love Your Weekend' with Alan Titchmarsh resulted in £1,000+ worth of online sales in 10 minutes. It will use the investment to expand its microbrewery, increase production 4 times to meet future demand, and increase brand awareness.

Pitch Rated

77%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,349,997
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph